Shandong Sito Bio-technology Co Ltd (SHE:300583) — Stock Price
Shandong Sito Bio-technology Co Ltd (SHE:300583) is currently trading at CN¥13.03 CNY, up 2.12% today. Over the past 52 weeks, shares have ranged between CN¥10.95 and CN¥18.37. This page tracks Shandong Sito Bio-technology Co Ltd's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 300583 market cap overview.
Shandong Sito Bio-technology Co Ltd (300583) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Shandong Sito Bio-technology Co Ltd's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Shandong Sito Bio-technology Co Ltd Income Statement — Revenue, Profit & Earnings by Year
Shandong Sito Bio-technology Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | CN¥970.60 Million | CN¥1.28 Billion | CN¥1.31 Billion | CN¥1.20 Billion | CN¥913.19 Million |
| Cost of Revenue | CN¥784.90 Million | CN¥1.01 Billion | CN¥1.04 Billion | CN¥937.04 Million | CN¥805.58 Million |
| Gross Profit | CN¥185.70 Million | CN¥268.31 Million | CN¥272.81 Million | CN¥265.59 Million | CN¥107.61 Million |
| Research & Development | CN¥58.38 Million | CN¥55.08 Million | CN¥50.21 Million | CN¥49.73 Million | CN¥45.01 Million |
| SG&A | CN¥39.69 Million | CN¥42.83 Million | CN¥37.27 Million | CN¥35.32 Million | CN¥30.99 Million |
| Total Operating Expenses | CN¥287.77 Million | CN¥235.57 Million | CN¥189.13 Million | CN¥168.53 Million | CN¥187.12 Million |
| Operating Income | CN¥-102.06 Million | CN¥32.74 Million | CN¥49.22 Million | CN¥55.97 Million | CN¥-186.16 Million |
| EBITDA | CN¥102.75 Million | CN¥264.71 Million | CN¥192.38 Million | CN¥220.20 Million | CN¥-15.35 Million |
| EBIT | CN¥-71.90 Million | CN¥91.14 Million | CN¥84.80 Million | CN¥84.50 Million | CN¥-158.47 Million |
| Interest Expense | CN¥35.23 Million | CN¥40.86 Million | CN¥38.88 Million | CN¥31.57 Million | CN¥35.51 Million |
| Income Before Tax | CN¥-102.75 Million | CN¥53.48 Million | CN¥47.91 Million | CN¥54.29 Million | CN¥-192.45 Million |
| Income Tax Expense | CN¥-1.42 Million | CN¥4.93 Million | CN¥5.43 Million | CN¥18.50 Million | CN¥-2.83 Million |
| Net Income | CN¥-88.77 Million | CN¥45.60 Million | CN¥41.97 Million | CN¥36.21 Million | CN¥-179.81 Million |
Shandong Sito Bio-technology Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Shandong Sito Bio-technology Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | CN¥3.03 Billion | CN¥3.24 Billion | CN¥3.00 Billion | CN¥2.97 Billion | CN¥2.84 Billion |
| Total Current Assets | CN¥1.28 Billion | CN¥1.40 Billion | CN¥1.14 Billion | CN¥1.08 Billion | CN¥1.14 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | CN¥349.75 Million | CN¥383.20 Million | CN¥285.22 Million | CN¥301.81 Million | CN¥171.37 Million |
| Inventory | CN¥644.88 Million | CN¥722.62 Million | CN¥608.26 Million | CN¥531.26 Million | CN¥532.40 Million |
| Property, Plant & Equipment | — | — | CN¥1.61 Billion | CN¥1.64 Billion | CN¥1.43 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CN¥1.14 Billion | CN¥1.17 Billion | CN¥1.22 Billion | CN¥1.24 Billion | CN¥1.15 Billion |
| Total Current Liabilities | CN¥1.02 Billion | CN¥986.76 Million | CN¥1.08 Billion | CN¥1.05 Billion | CN¥940.73 Million |
| Long-term Debt | CN¥74.28 Million | CN¥108.34 Million | CN¥122.70 Million | CN¥161.97 Million | CN¥191.64 Million |
| Net Debt | CN¥466.19 Million | CN¥504.11 Million | CN¥511.55 Million | CN¥509.67 Million | CN¥313.56 Million |
| Total Stockholder Equity | CN¥1.84 Billion | CN¥2.01 Billion | CN¥1.72 Billion | CN¥1.68 Billion | CN¥1.64 Billion |
| Retained Earnings | CN¥278.70 Million | CN¥452.83 Million | CN¥415.06 Million | CN¥374.59 Million | CN¥350.46 Million |
Shandong Sito Bio-technology Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Shandong Sito Bio-technology Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥194.46 Million | CN¥-92.85 Million | CN¥145.34 Million | CN¥227.35 Million | CN¥254.60 Million |
| Capital Expenditures | CN¥65.53 Million | CN¥94.06 Million | CN¥143.68 Million | CN¥388.92 Million | CN¥242.60 Million |
| Free Cash Flow | CN¥128.93 Million | CN¥-186.90 Million | CN¥1.66 Million | CN¥-161.57 Million | CN¥12.00 Million |
| Investing Cash Flow | CN¥-57.31 Million | CN¥-103.78 Million | CN¥-140.74 Million | CN¥-361.48 Million | CN¥-29.23 Million |
| Financing Cash Flow | CN¥-163.04 Million | CN¥319.77 Million | CN¥-4.99 Million | CN¥-47.67 Million | CN¥-140.73 Million |
| Dividends Paid | CN¥112.85 Million | CN¥32.28 Million | CN¥1.60 Million | CN¥24.52 Million | CN¥5.51 Million |
| Stock-Based Compensation | — | — | — | — | CN¥-4.83 Million |
| Depreciation | CN¥174.65 Million | CN¥173.57 Million | CN¥163.23 Million | CN¥135.45 Million | CN¥142.87 Million |
| Change in Cash | CN¥-24.64 Million | CN¥122.89 Million | CN¥-2.31 Million | CN¥-182.43 Million | CN¥82.47 Million |
Shandong Sito Bio-technology Co Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Shandong Sito Bio-technology Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 30, 2025 | -0.09 | — | — |
| Jun 30, 2025 | -0.13 | — | — |
| Jun 20, 2025 | -0.15 | — | — |
| Dec 31, 2024 | -0.55 | — | — |
| Sep 30, 2024 | 0.01 | — | — |
| Jun 30, 2024 | 0.05 | — | — |
| Jun 21, 2024 | 0.02 | — | — |
| Dec 31, 2023 | -0.08 | — | — |